Terns Pharmaceuticals, Inc. financial data

Symbol
TERN on Nasdaq
Location
1065 East Hillsdale Blvd., Suite 100, Foster City, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.4K % -7.44%
Debt-to-equity 5.08 % +11.2%
Return On Equity -30 % +8.58%
Return On Assets -28.5 % +9.03%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 90.1M shares +6.05%
Common Stock, Shares, Outstanding 87.5M shares +3.06%
Entity Public Float 427M USD +4.35%
Common Stock, Value, Issued 9K USD +12.5%
Weighted Average Number of Shares Outstanding, Basic 91.7M shares +17.8%
Weighted Average Number of Shares Outstanding, Diluted 91.7M shares +17.8%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 31.5M USD +3.51%
Costs and Expenses 108M USD +8.5%
Operating Income (Loss) -108M USD -8.5%
Nonoperating Income (Expense) 14.3M USD +17.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -94.2M USD -7.28%
Income Tax Expense (Benefit) 238K USD -11.5%
Net Income (Loss) Attributable to Parent -94.4M USD -7.22%
Earnings Per Share, Basic -1 USD/shares +13.6%
Earnings Per Share, Diluted -1 USD/shares +13.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 151M USD -44.2%
Marketable Securities, Current 145M USD +41.2%
Assets, Current 300M USD -20.2%
Property, Plant and Equipment, Net 59K USD -80%
Operating Lease, Right-of-Use Asset 938K USD -31.8%
Other Assets, Noncurrent 359K USD +541%
Assets 302M USD -20.2%
Accounts Payable, Current 2.95M USD +64.9%
Employee-related Liabilities, Current 4.24M USD -0.91%
Liabilities, Current 15.4M USD +34.8%
Accrued Income Taxes, Noncurrent 1.63M USD +23.5%
Operating Lease, Liability, Noncurrent 570K USD -44.8%
Liabilities 17.6M USD +27.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 109K USD -31.9%
Retained Earnings (Accumulated Deficit) -494M USD -23.6%
Stockholders' Equity Attributable to Parent 284M USD -22.1%
Liabilities and Equity 302M USD -20.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -24.4M USD -7.2%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 1.96M USD -75.5%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 87.5M shares +3.06%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -22.4M USD -51.2%
Deferred Tax Assets, Valuation Allowance 78.2M USD +31.2%
Deferred Tax Assets, Gross 620K USD +241%
Operating Lease, Liability 1.03M USD -21.1%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -94.5M USD -8.51%
Lessee, Operating Lease, Liability, to be Paid 1.15M USD -25.9%
Property, Plant and Equipment, Gross 2.11M USD -0.05%
Operating Lease, Liability, Current 459K USD +68.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 116K USD -51.9%
Deferred Tax Assets, Operating Loss Carryforwards 28M USD +40.5%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 5.54M USD -26.2%
Additional Paid in Capital 778M USD +1.84%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 55K USD -32.9%
Share-based Payment Arrangement, Expense 13.1M USD -17.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%